Cannabis prescriptions are becoming more common in the UK, whether via NHS-approved routes or through private clinics. But how does this affect workplace drug testing and occupational health practice? In this CPD-focused episode, toxicologist Helen Vangikar explores:

• The difference between NHS-authorised cannabis-based medicinal products (per the BNF) and privately issued prescriptions.
• Why some organisations (e.g., Network Rail) will only accept BNF-listed cannabis prescriptions.
• How Medical Review Officers should handle positive test results when legitimate prescriptions are involved.
• The analytical challenges in laboratories—why they can’t distinguish private vs. street cannabis.
• The need for consistent policy development across sectors and internationally.
• The role of CBD vs. THC in testing and future trends in testing approaches and legal frameworks.

This episode offers occupational health professionals valuable insights to stay informed and confident in their practice.

 Resources & Links

• Helen Vangikar’s website: helenvangikar.com
• Connect with Helen on LinkedIn: LinkedIn Profile
• Society of Occupational Medicine (SOM): som.org.uk
• Faculty of Occupational Medicine (FOM): fom.ac.uk

The SOM podcast is sponsored by Orchid Live - specialist occupational health software used by a number of SOM members to run every aspect of their occupational health operations. They hold healthcare records for over 1 million UK workers and work with both in-house OH teams and OH providers. You can find out more at OrchidLive.com.